Evidence map›Paper›PMID 38097589›Full record

ReviewNature reviews. Disease primers2023

Typhoid fever.

James E Meiring, Farhana Khanam, Buddha Basnyat, Richelle C Charles, John A Crump, Frederic Debellut, Kathryn E Holt, Samuel Kariuki, Emmanuel Mugisha, Kathleen M Neuzil and 5 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Disease primers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
15.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Genomic analysis ofMicrobial genomics · 2026
    Article
  7. Article
  8. Multivalent vaccines for invasiveInfection and immunity · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 12 institutions in 8 countries.

James E MeiringDivision of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.
Farhana KhanamInternational Centre for Diarrhoel Disease Research, Dhaka, Bangladesh.
Buddha BasnyatOxford University Clinical Research Unit, Kathmandu, Nepal.
Richelle C CharlesMassachusetts General Hospital, Harvard Medical School, Harvard T.H. Chan School of Public Health, Boston, MA, USA.ORCID 0000-0002-8881-1849
John A CrumpCentre for International Health, University of Otago, Dunedin, New Zealand.ORCID 0000-0002-4529-102X
Frederic DebellutCenter for Vaccine Innovation and Access, PATH, Geneva, Switzerland.ORCID 0000-0002-3027-2838
Kathryn E HoltDepartment of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.
Samuel KariukiCentre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.ORCID 0000-0003-3209-9503
Emmanuel MugishaCenter for Vaccine Innovation and Access, PATH, Seattle, WA, USA.
Kathleen M NeuzilCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
Christopher M ParryDepartment of Clinical Sciences and Education, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, UK.
Virginia E PitzerDepartment of Epidemiology of Microbial Diseases and Public Health Modelling Unit, Yale School of Public Health, Yale University, New Haven, CT, USA.
Andrew J PollardOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.ORCID 0000-0001-7361-719X
Firdausi QadriInternational Centre for Diarrhoel Disease Research, Dhaka, Bangladesh.
Melita A GordonMalawi-Liverpool-Wellcome Programme, Blantyre, Malawi. magordon@liverpool.ac.uk.ORCID 0000-0002-0629-0884
International Centre for Diarrhoeal Disease Research · BDUniversity of Liverpool · GBHarvard University · USKathmandu University · NPKenya Medical Research Institute · KELiverpool School of Tropical Medicine · GBLondon School of Hygiene & Tropical Medicine · GBProgram for Appropriate Technology in Health · USUniversity of Maryland, Baltimore · USUniversity of Otago · NZUniversity of Oxford · GBYale University · US

Funding

Investigating Febrile Deaths in Tanzania (INDITe)R01AI121378 · NIAID · DUKE UNIVERSITY · PI RUBACH, MATTHEW P · 2016 to 2020
$2.7M
Integrating geographical and genetic mapping of salmonella disease in an endemicR01AI099525 · NIAID · KENYA MEDICAL RESEARCH INSTITUTE (KEMRI) · PI GUNN, JOHN S, KARIUKI, SAMUEL M · 2013 to 2024
$1.3M
NIAID NIH HHS R01 AI099525NIAID NIH HHS R01 AI121378
6 · The paper itself

Abstract

Typhoid fever is an invasive bacterial disease associated with bloodstream infection that causes a high burden of disease in Africa and Asia. Typhoid primarily affects individuals ranging from infants through to young adults. The causative organism, Salmonella enterica subsp. enterica serovar Typhi is transmitted via the faecal-oral route, crossing the intestinal epithelium and disseminating to systemic and intracellular sites, causing an undifferentiated febrile illness. Blood culture remains the practical reference standard for diagnosis of typhoid fever, where culture testing is available, but novel diagnostic modalities are an important priority under investigation. Since 2017, remarkable progress has been made in defining the global burden of both typhoid fever and antimicrobial resistance; in understanding disease pathogenesis and immunological protection through the use of controlled human infection; and in advancing effective vaccination programmes through strategic multipartner collaboration and targeted clinical trials in multiple high-incidence priority settings. This Primer thus offers a timely update of progress and perspective on future priorities for the global scientific community.

Indexed as

Typhoid FeverFeverHumansInfantSalmonellaSalmonella typhiYoung Adult

Identifiers

PMID38097589
OpenAlexW4389742051

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.